Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LX1606 in symptomatic carcinoid syndrome
NCT01104415Phase 2Completed
- Sponsor
- Lexicon Pharmaceuticals, Inc.
- Start
- Jun 2010
- Primary completion
- Feb 2014
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of telotristat ethyl in Carcinoid Syndrome (CS), sponsored by Lexicon Pharmaceuticals, Inc.. Started Jun 2010; status: completed.
02
Drugs
telotristat ethyl
03
Conditions
Carcinoid Syndrome (CS)
Beyond the preview
Go deeper on NCT01104415.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01104415.